An Auto-luminescent Fluorescent BCG Whole Blood Assay to Enable Evaluation of Paediatric Mycobacterial Responses Using Minimal Blood Volumes

Introduction: Understanding protective human immunity against mycobacteria is critical to developing and evaluating new vaccines against tuberculosis. Children are the most susceptible population to infection, disease, and death from tuberculosis, but also have the strongest evidence of BCG-inducibl...

Full description

Bibliographic Details
Main Authors: Robindra Basu Roy, Basil Sambou, Iria Uhía, Sophie Roetynck, Brian D. Robertson, Beate Kampmann
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Pediatrics
Subjects:
BCG
Online Access:https://www.frontiersin.org/article/10.3389/fped.2019.00151/full
id doaj-a723b0a8fefe47b4940111b448922315
record_format Article
spelling doaj-a723b0a8fefe47b4940111b4489223152020-11-25T02:50:07ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602019-04-01710.3389/fped.2019.00151431822An Auto-luminescent Fluorescent BCG Whole Blood Assay to Enable Evaluation of Paediatric Mycobacterial Responses Using Minimal Blood VolumesRobindra Basu Roy0Robindra Basu Roy1Basil Sambou2Iria Uhía3Sophie Roetynck4Brian D. Robertson5Beate Kampmann6Beate Kampmann7Beate Kampmann8Department of Paediatrics, Centre for International Child Health, Imperial College London, London, United KingdomVaccines & Immunity Theme, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine (LSHTM), Banjul, The GambiaVaccines & Immunity Theme, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine (LSHTM), Banjul, The GambiaMRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United KingdomVaccines & Immunity Theme, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine (LSHTM), Banjul, The GambiaMRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United KingdomDepartment of Paediatrics, Centre for International Child Health, Imperial College London, London, United KingdomVaccines & Immunity Theme, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine (LSHTM), Banjul, The GambiaFaculty of Infectious and Tropical Diseases, The Vaccine Centre, London School of Hygiene and Tropical Medicine, London, United KingdomIntroduction: Understanding protective human immunity against mycobacteria is critical to developing and evaluating new vaccines against tuberculosis. Children are the most susceptible population to infection, disease, and death from tuberculosis, but also have the strongest evidence of BCG-inducible protection. Limited amounts of blood can be obtained for research purposes in paediatrics and therefore there is a need for high-yield, low-volume, human immunology assays.Methods: We transformed BCG Danish with plasmids encoding luciferase full operon derived from Photorhabdus luminescens together with Green Fluorescent Protein and antibiotic selection markers. We characterised the luminescent and fluorescent properties of this recombinant BCG strain (BCG-GFP-LuxFO) using a luminometer and flow cytometry and developed a paediatric whole blood in vitro infection model.Results: Luminescence of BCG-GFP-LuxFO correlated with optical density (Spearman Rank Correlation coefficient r = 0.985, p < 0.0001) and colony forming units (CFUs) in liquid culture medium (r = 0.971, p < 0.0001). Fluorescence of BCG-GFP-LuxFO in paediatric whole blood was confirmed by flow cytometry in granulocytes and monocytes 1 h following infection. Luminescence of BCG-GFP-LuxFO in whole blood corresponded with CFUs (r = 0.7123, p < 0.0001).Conclusion: The BCG-GFP-LuxFO assay requires 225 μL whole blood per sample, from which serial luminescence measurements can be obtained, together with biochemical analysis of supernatants and cellular assay applications using its fluorescent properties. This offers the opportunity to study human-mycobacterial interactions using multiple experimental modalities with only minimal blood volumes. It is therefore a valuable method for investigating paediatric immunity to tuberculosis.https://www.frontiersin.org/article/10.3389/fped.2019.00151/fulltuberculosispaediatricBCGimmunologymycobacterial growth inhibition assay
collection DOAJ
language English
format Article
sources DOAJ
author Robindra Basu Roy
Robindra Basu Roy
Basil Sambou
Iria Uhía
Sophie Roetynck
Brian D. Robertson
Beate Kampmann
Beate Kampmann
Beate Kampmann
spellingShingle Robindra Basu Roy
Robindra Basu Roy
Basil Sambou
Iria Uhía
Sophie Roetynck
Brian D. Robertson
Beate Kampmann
Beate Kampmann
Beate Kampmann
An Auto-luminescent Fluorescent BCG Whole Blood Assay to Enable Evaluation of Paediatric Mycobacterial Responses Using Minimal Blood Volumes
Frontiers in Pediatrics
tuberculosis
paediatric
BCG
immunology
mycobacterial growth inhibition assay
author_facet Robindra Basu Roy
Robindra Basu Roy
Basil Sambou
Iria Uhía
Sophie Roetynck
Brian D. Robertson
Beate Kampmann
Beate Kampmann
Beate Kampmann
author_sort Robindra Basu Roy
title An Auto-luminescent Fluorescent BCG Whole Blood Assay to Enable Evaluation of Paediatric Mycobacterial Responses Using Minimal Blood Volumes
title_short An Auto-luminescent Fluorescent BCG Whole Blood Assay to Enable Evaluation of Paediatric Mycobacterial Responses Using Minimal Blood Volumes
title_full An Auto-luminescent Fluorescent BCG Whole Blood Assay to Enable Evaluation of Paediatric Mycobacterial Responses Using Minimal Blood Volumes
title_fullStr An Auto-luminescent Fluorescent BCG Whole Blood Assay to Enable Evaluation of Paediatric Mycobacterial Responses Using Minimal Blood Volumes
title_full_unstemmed An Auto-luminescent Fluorescent BCG Whole Blood Assay to Enable Evaluation of Paediatric Mycobacterial Responses Using Minimal Blood Volumes
title_sort auto-luminescent fluorescent bcg whole blood assay to enable evaluation of paediatric mycobacterial responses using minimal blood volumes
publisher Frontiers Media S.A.
series Frontiers in Pediatrics
issn 2296-2360
publishDate 2019-04-01
description Introduction: Understanding protective human immunity against mycobacteria is critical to developing and evaluating new vaccines against tuberculosis. Children are the most susceptible population to infection, disease, and death from tuberculosis, but also have the strongest evidence of BCG-inducible protection. Limited amounts of blood can be obtained for research purposes in paediatrics and therefore there is a need for high-yield, low-volume, human immunology assays.Methods: We transformed BCG Danish with plasmids encoding luciferase full operon derived from Photorhabdus luminescens together with Green Fluorescent Protein and antibiotic selection markers. We characterised the luminescent and fluorescent properties of this recombinant BCG strain (BCG-GFP-LuxFO) using a luminometer and flow cytometry and developed a paediatric whole blood in vitro infection model.Results: Luminescence of BCG-GFP-LuxFO correlated with optical density (Spearman Rank Correlation coefficient r = 0.985, p < 0.0001) and colony forming units (CFUs) in liquid culture medium (r = 0.971, p < 0.0001). Fluorescence of BCG-GFP-LuxFO in paediatric whole blood was confirmed by flow cytometry in granulocytes and monocytes 1 h following infection. Luminescence of BCG-GFP-LuxFO in whole blood corresponded with CFUs (r = 0.7123, p < 0.0001).Conclusion: The BCG-GFP-LuxFO assay requires 225 μL whole blood per sample, from which serial luminescence measurements can be obtained, together with biochemical analysis of supernatants and cellular assay applications using its fluorescent properties. This offers the opportunity to study human-mycobacterial interactions using multiple experimental modalities with only minimal blood volumes. It is therefore a valuable method for investigating paediatric immunity to tuberculosis.
topic tuberculosis
paediatric
BCG
immunology
mycobacterial growth inhibition assay
url https://www.frontiersin.org/article/10.3389/fped.2019.00151/full
work_keys_str_mv AT robindrabasuroy anautoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT robindrabasuroy anautoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT basilsambou anautoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT iriauhia anautoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT sophieroetynck anautoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT briandrobertson anautoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT beatekampmann anautoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT beatekampmann anautoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT beatekampmann anautoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT robindrabasuroy autoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT robindrabasuroy autoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT basilsambou autoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT iriauhia autoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT sophieroetynck autoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT briandrobertson autoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT beatekampmann autoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT beatekampmann autoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
AT beatekampmann autoluminescentfluorescentbcgwholebloodassaytoenableevaluationofpaediatricmycobacterialresponsesusingminimalbloodvolumes
_version_ 1724739977603973120